These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 22043640)
41. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Edelstein C; Shorr N; Jacobs J; Balch K; Goldberg R Dermatol Surg; 1998 Nov; 24(11):1208-12. PubMed ID: 9834740 [TBL] [Abstract][Full Text] [Related]
42. Chemodenervation for facial dystonias and wrinkles. Harrison AR Curr Opin Ophthalmol; 2003 Oct; 14(5):241-5. PubMed ID: 14502050 [TBL] [Abstract][Full Text] [Related]
43. Botulinum toxin a for the treatment of hyperkinetic wrinkle lines. Park MY; Ahn KY Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):148S-150S. PubMed ID: 14504497 [No Abstract] [Full Text] [Related]
46. Shrink that frown! Botulinum toxin therapy is lifting the face of psychiatry. Wollmer MA; Neumann I; Magid M; Kruger TH G Ital Dermatol Venereol; 2018 Aug; 153(4):540-548. PubMed ID: 29667799 [TBL] [Abstract][Full Text] [Related]
47. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion. Flynn TC; Clark RE Dermatol Surg; 2003 May; 29(5):519-22; discussion 522. PubMed ID: 12752521 [TBL] [Abstract][Full Text] [Related]
48. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides. Hantash BM; Gladstone HB Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381 [TBL] [Abstract][Full Text] [Related]
49. The adjunctive usage of botulinum toxin. Carruthers J; Carruthers A Dermatol Surg; 1998 Nov; 24(11):1244-7. PubMed ID: 9834746 [TBL] [Abstract][Full Text] [Related]
50. Complications of botulinum A exotoxin for hyperfunctional lines. Matarasso SL Dermatol Surg; 1998 Nov; 24(11):1249-54. PubMed ID: 9834747 [TBL] [Abstract][Full Text] [Related]
51. Botulinum toxin A for the treatment of lateral periorbital rhytids. Kim DW; Cundiff J; Toriumi DM Facial Plast Surg Clin North Am; 2003 Nov; 11(4):445-51. PubMed ID: 15062248 [TBL] [Abstract][Full Text] [Related]
52. The role of clostridium botulinum: a neurotoxin in clinical dermatology. Matarasso SL West J Med; 1998 Oct; 169(4):226. PubMed ID: 9795588 [No Abstract] [Full Text] [Related]
53. BOTOX therapy for every dental practice. Malcmacher L Dent Today; 2009 Aug; 28(8):114, 116-7. PubMed ID: 19715075 [No Abstract] [Full Text] [Related]
54. Quantitative Evaluation of the Effects of Botulinum Toxin Injection Into the Temporalis Muscles and Parotid Glands. Lee MH; Chung SR; Youn CS; Won CH Dermatol Surg; 2020 Mar; 46(3):436-439. PubMed ID: 31490304 [No Abstract] [Full Text] [Related]
55. Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles. Blitzer A; Binder WJ Facial Plast Surg Clin North Am; 2001 Aug; 9(3):395-404. PubMed ID: 11457703 [TBL] [Abstract][Full Text] [Related]
56. Botulinum neurotoxin type A in the masseter muscle: effects on incisor eruption in rabbits. Navarrete AL; Rafferty KL; Liu ZJ; Ye W; Greenlee GM; Herring SW Am J Orthod Dentofacial Orthop; 2013 Apr; 143(4):499-506. PubMed ID: 23561411 [TBL] [Abstract][Full Text] [Related]
58. Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes. Glogau RG Clin J Pain; 2002; 18(6 Suppl):S191-7. PubMed ID: 12569968 [TBL] [Abstract][Full Text] [Related]
59. Anatomic considerations for treatment with botulinum toxin. Petrus GM; Lewis D; Maas CS Facial Plast Surg Clin North Am; 2007 Feb; 15(1):1-9, v. PubMed ID: 17317550 [TBL] [Abstract][Full Text] [Related]
60. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face. Maas CS Facial Plast Surg Clin North Am; 2006 Aug; 14(3):241-5. PubMed ID: 16908391 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]